Samar H. Ibrahim

Biography

Samar Ibrahim, M.B.Ch.B is an Associate Professor of Pediatrics and Physiology, Division of Pediatric Gastroenterology and Hepatology at Mayo Clinic. Dr. Ibrahim is a pediatric transplant hepatologist and a physician scientist. Dr. Ibrahim is the Principal Investigator of the NIH-funded lipotoxicity and liver inflammation laboratory at Mayo Clinic. She studies the mechanism of liver injury and inflammation in nonalcoholic steatohepatitis (NASH), with the goal to identify novel biomarkers and mechanism-based therapeutic targets. Her recently published work identified the vascular adhesion molecule 1 (VCAM1) as a potential novel therapeutic target in NASH. Dr. Ibrahim and her research team have examined the role of extracellular vesicles as biomarkers, as well as mediators of intercellular communication in NASH pathobiology. They defined the role of integrin β1-enriched extracellular vesicles in NASH. She is the director of the Pilot and Feasibility program at the Digestive Disease Center at Mayo Clinic. Dr. Ibrahim has served on NIDDK study sections, as well as a reviewer for international funding agencies. Dr. Ibrahim has mentored numerous medical students, residents, and postdoctoral fellows. She is the pediatric associate editor for “HEPATOLOGY” and a steering committee member of the AASLD pediatric special interest group, and a membber of the AASLD basic scince committee. She is a NASPGHAN fellow, and a member of the NASPGHAN hepatology committee and the SPLIT education and advocacy committees. Dr. Ibrahim serves as the Medical Director of the Pediatric Liver Transplant Program at Mayo clinic and is interested in studying factors responsible for late liver graft dysfunction, as well as developing models that better predict the acuity of the pediatric liver transplant candidate on the wait list.